Alessandro Federico

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Paolo Caraceni, Oliviero Riggio, Paolo Angeli et al. · The Lancet · 2018 · 499 citations · Full text

Hepatology, Decompensated Cirrhosis, Liver Physiology +6

Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases

C. Loguercio, Alessandro Federico, Concetta Tuccillo et al. · Journal of Clinical Gastroenterology · 2005 · 444 citations

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

Cristiana Bianco, Oveis Jamialahmadi, Serena Pelusi et al. · Journal of Hepatology · 2020 · 340 citations · Full text

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

C. Loguercio, Pietro Andreoné, Ciprian Brisc et al. · Free Radical Biology and Medicine · 2012 · 249 citations · Full text

Obesity, Metabolic Syndrome, Nutrition +11

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

Javier Molina‐Infante, Marco Romano, Miguel Fernández‐Bermejo et al. · Gastroenterology · 2013 · 197 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +10